Poli, Usha Rani Reddy

Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

Basu, P., Malvi, S. G., Joshi, S., Bhatla, N., Muwonge, R., Lucas, E., Verma, Y., Esmy, P. O., Poli, U. R. R., Shah, A., et al. (2021) · The Lancet Oncology

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 272

Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study

Sankaranarayanan, R., Prabhu, P. R., Pawlita, M., Gheit, T., Bhatla, N., Muwonge, R., Nene, B. M., Esmy, P. O., Joshi, S., Poli, U. R. R., et al. (2016) · The Lancet Oncology

Cervical Cancer and HPV ResearchGenital Health and Disease

Cited by 242

Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an Indian study

Sankaranarayanan, R., Joshi, S., Muwonge, R., Esmy, P. O., Basu, P., Prabhu, P., Bhatla, N., Nene, B. M., Shaw, J., Poli, U. R. R., et al. (2018) · Vaccine

Cervical Cancer and HPV ResearchWomen's cancer prevention and management

Cited by 164

Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India

Sowjanya, A. P., Jain, M., Poli, U. R., Padma, S., Das, M., Shah, K. V., Rao, B., Devi, R. R., Gravitt, P. E., & Ramakrishna, G. (2005) · BMC Infectious Diseases

Cervical Cancer and HPV ResearchReproductive tract infections research

Cited by 155